Fazekas F - Search Results

1

Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis.

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Schmidt R, et al. Among authors: fazekas f. J Neurol Sci. 2006 Jun 15;245(1-2):3-7. doi: 10.1016/j.jns.2005.06.018. Epub 2006 Apr 19. J Neurol Sci. 2006. PMID: 16626755 Review.

2

Evolution of white matter lesions.

Schmidt R, Schmidt H, Kapeller P, Lechner A, Fazekas F. Schmidt R, et al. Among authors: fazekas f. Cerebrovasc Dis. 2002;13 Suppl 2:16-20. doi: 10.1159/000049145. Cerebrovasc Dis. 2002. PMID: 11901238 Review.

3

The natural course of MRI white matter hyperintensities.

Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R, Fazekas F. Schmidt R, et al. Among authors: fazekas f. J Neurol Sci. 2002 Nov 15;203-204:253-7. doi: 10.1016/s0022-510x(02)00300-3. J Neurol Sci. 2002. PMID: 12417393 Review.

4

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

5

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F; Austrian Stroke Prevention Study. Schmidt R, et al. Among authors: fazekas f. Lancet. 2003 Jun 14;361(9374):2046-8. doi: 10.1016/s0140-6736(03)13616-1. Lancet. 2003. PMID: 12814718

6

MTI of white matter hyperintensities.

Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, Schmidt R. Fazekas F, et al. Brain. 2005 Dec;128(Pt 12):2926-32. doi: 10.1093/brain/awh567. Epub 2005 Jun 15. Brain. 2005. PMID: 15958507

7

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study.

Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, Matthews PM, Fazekas F. Schmidt R, et al. Among authors: fazekas f. Ann Neurol. 2005 Oct;58(4):610-6. doi: 10.1002/ana.20630. Ann Neurol. 2005. PMID: 16178017

8

Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study.

Rachbauer D, Kronbichler M, Ropele S, Enzinger C, Fazekas F. Rachbauer D, et al. Among authors: fazekas f. J Neurol Sci. 2006 May 15;244(1-2):11-6. doi: 10.1016/j.jns.2005.11.035. Epub 2006 Feb 9. J Neurol Sci. 2006. PMID: 16480742 Clinical Trial.

9

Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study.

Enzinger C, Smith S, Fazekas F, Drevin G, Ropele S, Nichols T, Behrens T, Schmidt R, Matthews PM. Enzinger C, et al. Among authors: fazekas f. J Neurol. 2006 Aug;253(8):1064-70. doi: 10.1007/s00415-006-0164-5. Epub 2006 Apr 10. J Neurol. 2006. PMID: 16607471

10

The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.

Fazekas F, Enzinger C, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S. Fazekas F, et al. J Neurol Sci. 2006 Jun 15;245(1-2):35-9. doi: 10.1016/j.jns.2005.08.018. Epub 2006 Apr 24. J Neurol Sci. 2006. PMID: 16631796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page